KASHIF ANWAR: Open Payments
NPI 1174800197 · EWING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 37 payments from 12 companies in 2025. Trend: 2023 $57 · 2024 $424 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $271 |
| Novo Nordisk Inc | 13 | $190 |
| Acera Surgical, Inc. | 2 | $41 |
| Exact Sciences Corporation | 2 | $40 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| HARMONY BIOSCIENCES LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: ZEPBOUND, Wegovy, MOUNJARO, Restrata Wound Matrix, Cologuard Collection Kit, BEXSERO, AUSTEDO XR, WAKIX.
Industry payments across NJ — which companies pay providers there.
